Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director
Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, announced key updates to its Board of Directors to bolster the company's growth in 2025 and beyond. As of January 1, 2025, Thomas E. Hogan has been confirmed as interim CEO, while maintaining his role on the Board, with plans to revert to chairman once a new CEO is appointed. Adam H. Clammer, Managing Partner of True Wind Capital Management, has taken on the role of board chairman, adhering to best practices in board governance by separating the CEO and board chair duties.
Additionally, Michael D. Capellas, with extensive leadership experience across top technology companies, joins Cellebrite's Board as a Class II director and the new lead independent director, replacing Adam Clammer. Capellas's notable roles include CEO positions at VCE, First Data , MCI, Compaq Computer , and President at Hewlett-Packard.
Capellas expressed enthusiasm for joining Cellebrite, highlighting his commitment to justice, safety, and security, and his alignment with the company's mission to combat child exploitation and trafficking.
Cellebrite (NASDAQ: CLBT), leader globale nelle soluzioni di investigazione digitale, ha annunciato aggiornamenti chiave al suo Consiglio di Amministrazione per sostenere la crescita dell'azienda nel 2025 e oltre. A partire dal 1° gennaio 2025, Thomas E. Hogan è stato confermato come CEO ad interim, mantenendo il suo ruolo nel Consiglio, con l'intenzione di tornare a essere presidente una volta nominato un nuovo CEO. Adam H. Clammer, Managing Partner di True Wind Capital Management, ha assunto il ruolo di presidente del consiglio, rispettando le migliori pratiche di governance separando i compiti di CEO e presidente del consiglio.
Inoltre, Michael D. Capellas, con una vasta esperienza di leadership in importanti aziende tecnologiche, entra a far parte del Consiglio di Cellebrite come direttore di Classe II e nuovo direttore indipendente principale, sostituendo Adam Clammer. I ruoli notevoli di Capellas includono posizioni di CEO presso VCE, First Data, MCI, Compaq Computer e Presidente presso Hewlett-Packard.
Capellas ha espresso entusiasmo per unirsi a Cellebrite, sottolineando il suo impegno per la giustizia, la sicurezza e la protezione, e la sua affinità con la missione dell'azienda di combattere lo sfruttamento e il traffico di minori.
Cellebrite (NASDAQ: CLBT), líder global en soluciones de investigación digital, anunció actualizaciones clave a su Junta Directiva para impulsar el crecimiento de la empresa en 2025 y más allá. A partir del 1 de enero de 2025, Thomas E. Hogan ha sido confirmado como CEO interino, mientras mantiene su cargo en la Junta, con planes de volver a ser presidente una vez que se designe un nuevo CEO. Adam H. Clammer, Socio Gerente de True Wind Capital Management, ha asumido el cargo de presidente de la junta, cumpliendo con las mejores prácticas de gobernanza al separar las funciones del CEO y el presidente de la junta.
Además, Michael D. Capellas, con una amplia experiencia en liderazgo en las principales empresas de tecnología, se une a la Junta de Cellebrite como director de Clase II y nuevo director independiente principal, reemplazando a Adam Clammer. Los roles notables de Capellas incluyen posiciones como CEO en VCE, First Data, MCI, Compaq Computer, y Presidente en Hewlett-Packard.
Capellas expresó su entusiasmo por unirse a Cellebrite, destacando su compromiso con la justicia, la seguridad y la protección, y su alineación con la misión de la empresa de combatir la explotación y el tráfico de menores.
셀레브라이트 (NASDAQ: CLBT), 디지털 조사 솔루션의 글로벌 리더, 2025년 및 그 이후에 대한 회사의 성장을 강화하기 위해 이사회의 주요 업데이트를 발표했습니다. 2025년 1월 1일부터 Thomas E. Hogan이 임시 CEO로 확인되었으며 이사회 역할을 계속 유지하며, 새로운 CEO가 임명되면 회장으로 복귀할 계획입니다. True Wind Capital Management의 관리 파트너인 Adam H. Clammer가 이사회의 회장 역할을 맡아 CEO와 이사장 역할을 분리하여 이사회 거버넌스의 모범 사례를 준수합니다.
또한, 주요 기술 기업에서 광범위한 리더십 경험을 가진 Michael D. Capellas가 класса II 이사로 셀레브라이트 이사회에 합류하며 새로운 주요 독립 이사가 되어 Adam Clammer를 대체합니다. Capellas의 주목할 만한 역할에는 VCE, First Data, MCI, Compaq Computer의 CEO 및 Hewlett-Packard의 대통령이 포함됩니다.
Capellas는 셀레브라이트에 합류하게 되어 기쁘다고 표현하며, 정의, 안전 및 보안에 대한 그의 헌신과 아동 착취 및 인신매매에 맞서 싸우는 회사의 사명에 대한 자신의 동조를 강조했습니다.
Cellebrite (NASDAQ: CLBT), leader mondial des solutions d'investigation numérique, a annoncé des mises à jour clés de son Conseil d'Administration pour soutenir la croissance de l'entreprise en 2025 et au-delà. À partir du 1er janvier 2025, Thomas E. Hogan a été confirmé comme PDG par intérim, tout en maintenant son rôle au sein du Conseil, avec l'intention de redevenir président une fois qu'un nouveau PDG sera nommé. Adam H. Clammer, Partenaire Gérant de True Wind Capital Management, a pris le rôle de président du conseil, respectant les meilleures pratiques de gouvernance en séparant les fonctions de PDG et de président du conseil.
De plus, Michael D. Capellas, avec une vaste expérience en leadership au sein des plus grandes entreprises technologiques, rejoint le Conseil de Cellebrite en tant que directeur de Classe II et nouveau directeur indépendant principal, remplaçant Adam Clammer. Les rôles notables de Capellas incluent des postes de PDG chez VCE, First Data, MCI, Compaq Computer et Président chez Hewlett-Packard.
Capellas a exprimé son enthousiasme à rejoindre Cellebrite, soulignant son engagement envers la justice, la sécurité et la protection, ainsi que son alignement avec la mission de l'entreprise de lutter contre l'exploitation et le trafic d'enfants.
Cellebrite (NASDAQ: CLBT), ein globaler Marktführer im Bereich digitale Ermittlungslösungen, hat wichtige Änderungen im Vorstand angekündigt, um das Wachstum des Unternehmens im Jahr 2025 und darüber hinaus zu fördern. Ab dem 1. Januar 2025 wurde Thomas E. Hogan als vorläufiger CEO bestätigt, während er seine Rolle im Vorstand beibehält, mit dem Plan, wieder Vorsitzender zu werden, sobald ein neuer CEO ernannt wurde. Adam H. Clammer, Managing Partner von True Wind Capital Management, hat die Rolle des Vorstandsvorsitzenden übernommen und damit die besten Praktiken der Vorstandsgovernance beachtet, indem er die Aufgaben des CEOs und des Vorsitzenden trennt.
Darüber hinaus wird Michael D. Capellas, der über umfangreiche Führungserfahrung in führenden Technologieunternehmen verfügt, als Direktor der Klasse II in den Vorstand von Cellebrite aufgenommen und ist der neue führende unabhängige Direktor, der Adam Clammer ersetzt. Zu den bemerkenswerten Positionen von Capellas gehören CEO-Positionen bei VCE, First Data, MCI, Compaq Computer sowie Präsident bei Hewlett-Packard.
Capellas äußerte seine Begeisterung für den Beitritt zu Cellebrite und betonte sein Engagement für Gerechtigkeit, Sicherheit und Schutz sowie seine Übereinstimmung mit der Mission des Unternehmens, gegen die Ausbeutung und den Menschenhandel von Kindern vorzugehen.
- Appointment of Michael D. Capellas, a highly experienced executive, to the Board of Directors as lead independent director.
- Thomas E. Hogan confirmed as interim CEO, ensuring leadership continuity.
- Adam H. Clammer assumes duties of board chairman, enhancing governance by separating CEO and board chair roles.
- Interim CEO appointment indicates potential uncertainty until a permanent CEO is found.
Thomas E. Hogan confirmed as interim CEO
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company’s continued growth into 2025 and beyond.
As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company’s Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO.
As part of Cellebrite’s ongoing commitment to best practices in board governance, specifically those related to the separation of duties between the CEO and board chair, Adam H. Clammer, Managing Partner of True Wind Capital Management and Cellebrite’s current lead independent director, has assumed the duties of board chairman.
Finally, Cellebrite is pleased to announce that Michael D. Capellas, a distinguished executive with extensive leadership experience across a range of CIO, CEO and board chairman and director positions at a number of the world’s most successful software and technology companies, has been appointed to Cellebrite’s Board of Directors as a Class II director. In addition, he will serve as the Board’s lead independent director, replacing the role vacated by Adam Clammer. All appointments were effective January 1, 2025.
Michael D. Capellas has served as founder and CEO of Capellas Strategic Partners, a strategic technology advisory firm, since November 2012. His leadership experience includes serving as the founding Chairman and CEO of VCE (Virtual Computing Company) a joint venture between Cisco, EMC and VMware, which developed and commercialized an innovative platform for cloud computing; Chairman and CEO of First Data Corporation; CEO and director of MCI (previously WorldCom); Chairman, President and CEO of Compaq Computer Corporation and President of Hewlett-Packard Company following the merger of Compaq and Hewlett-Packard. Mr. Capellas currently serves as the lead independent director of Cisco Systems, Inc. (NASDAQ: CSCO) in addition to other current and past board assignments.
“I am personally delighted to welcome Michael to our board,” said Thomas E. Hogan. “Michael brings a wide range of powerful and complementary skills to an already strong board. His specific depth of experience as the CEO of multiple global leaders with the scale we aspire to, his prowess in products and technology as a legacy CIO and his track record of strategic insight and execution, align perfectly with Cellebrite’s priorities and ambitions.”
“I am thrilled to join Cellebrite’s board,” said Mr. Capellas. “I have a deep passion for justice, safety and security, and I bring a long history of global support for these causes. Cellebrite’s C2C platform empowers law enforcement, intelligence agencies and global leaders to accelerate justice and enhance community safety. I am particularly inspired by the Company’s ongoing efforts to combat child exploitation and trafficking – an issue I care about deeply. I look forward to collaborating with Tom, Adam, my fellow board directors and Cellebrite’s executive team to further the Company’s mission and drive meaningful impact.”
Cellebrite’s Board of Directors continues to be composed of 10 members. Detailed biographies of all Cellebrite directors are available here.
References to Websites and Social Media Platforms
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.
Caution Regarding Forward Looking Statements
This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include Mr. Hogan’s plans to revert to his position as chairman upon the eventual appointment of the new CEO; and Mr. Capellas’ intention to collaborate with Cellebrite’s board members and executive team to further the Company’s mission and drive meaningful impact. Such forward-looking statements including those with respect to commentary associated with future performance, strategies, prospects, and other aspects of Cellebrite’s business are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; failure to manage its growth effectively; Cellebrite’s ability to introduce new solutions and add-ons; its dependency on its customers renewing their subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange rates; lengthy sales cycle for some of Cellebrite’s solutions; near term declines in new or renewed agreements; risks associated with inability to retain qualified personnel and senior management; the security of Cellebrite’s operations and the integrity of its software solutions; risks associated with the negative publicity related to Cellebrite’s business and use of its products; risks related to Cellebrite’s intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite’s operations in Israel, including the ongoing Israel-Hamas war and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the SEC on March 21, 2024 and as amended on April 12, 2024, and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigation platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on Twitter at @Cellebrite.
Contacts:
Investors Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760
Media
Victor Ryan Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910
FAQ
What changes were announced in Cellebrite's Board of Directors?
What is the significance of Michael D. Capellas joining Cellebrite's Board?
Who is the new interim CEO of Cellebrite?
What role does Adam H. Clammer now hold at Cellebrite?
What does the appointment of Michael D. Capellas as lead independent director mean for Cellebrite?
When did the changes in Cellebrite's Board of Directors become effective?
What are Thomas E. Hogan's plans after serving as interim CEO?
